1 Home Unlabelled CHI's 13th Annual Structure-Based Drug Design Conference - Overview
21:59:00
A+ A-

CHI's 13th Annual Structure-Based Drug Design Conference - Overview

CHI's 13th Annual Structure-Based Drug Design Conference - Overview





At CHI/Bio-IT World's thirteenth annual Structure-Based Drug Design conference, you will hear
about developments in insilico technology, as well as experimental approaches useful for accurately
predicting and modeling the structures of proteins in structure-based drug design efforts. In addition,
examples of successful applications of such technology approaches to genome-to-drug lead
investigations will be addressed.

Advisory Board
Dr. Don Jacobs, University of North Carolina Charlotte
Dr. Jon Mason, Heptares Therapeutics Ltd.
Dr. Stephan Schurer, University of Miami
Dr. Xiayang Qiu, Pfizer, Inc.
Dr. David Dalgarno, ARIAD Pharmaceuticals, Inc.
Dr. Gergely Toth, University of Cambridge
Dr. Scot Mente, Pfizer Global R&D Groton Labs
Final Agenda 
Keynote Presentation

Tomi Sawyer-2013
Drugging the Undruggable:
Transforming Nature's α-Helix into Breakthrough Medicines

Tomi Sawyer, Ph.D., CSO, Aileron Therapeutics

 
Reasons to Attend:
  • HEAR about novel ligand-centric approach for force field calculation.
  • BE inspired to set up ambitious projects on SBDD using automated analytics pipeline and long-timescale explicit molecular simulation.
  • EXAMINE the role of water/solvent in structure-based drug design.
  • RE-DISCOVER the potential of fragment-based drug design through simulation of the complete binding process.
  • EXPLORE the epigenomic protein landscapes of cancer cells for drug design.
  • MEET potential collaborators from both academic and industry practitioners.
Sessions:
  • Structure-Based Drug Design for Kinase
  • Drug Resistance
  • Force Field Calculation
  • GPCR
  • Water & Solvation in Drug Design
  • Fragment-Based Drug Design
  • Protein-Protein Interaction
  • Epigenetic Targeting
 

MORNING SHORT COURSE (JUNE 19, 9:00 AM - 12:00 PM)*  
Structure-Based Drug Design for Epigenetic Targets
Instructor:
Johnathan R. Whetstine, Ph.D., Assistant Professor of Medicine, Harvard Medical School
Philip Fallon, Ph.D., Senior Medicinal Chemist, Domainex Ltd.


Click here to view details.
DINNER SHORT COURSE (JUNE 19, 6:00-8:00 PM)*  
Chemical Computing Group-DO NOT USE
A Uniform Framework for Computer-Aided Biologics Design

Instructor:
Chris Williams, Ph.D., Principal Scientist, Chemical Computing Group

Click here to view details.

*Separate registration required.